Laboratory tests and clinical significance of anti-3-hydroxy-3-methylglutaryl coenzyme A reductase antibody
Abstract
Anti-3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) antibody is a newly recognized autoantibody, which is associated with the use of statins and is considered as an immunological marker of necrotizing autoimmune myopathy (NAM). This article summarizes the discovery, laboratory tests and clinical significance of anti-HMGCR antibody.
DOI: 10.3969/j.issn.1672-6731.2016.09.005
Keywords
Hydroxymethylglutaryl CoA reductases; Immunoassay; Antilipemic agents; Review
This work is licensed under a Creative Commons Attribution 3.0 License.